AW
ABOS icon

Avion Wealth’s Acumen Pharmaceuticals ABOS Stock Holding History

Avion Wealth’s Portfolio ABOS Stock Details ABOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1K Buy
+500
New +$1.24K ﹤0.01% 1152

Other funds holding ABOS

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $614M AUM 19.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
KIA
Knollwood Investment Advisory Hunt Valley, Maryland $1.12B AUM 41.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Avion Wealth's ABOS Position: Q2 2026 in Review

Avion Wealth opened a new position in Acumen Pharmaceuticals (ABOS) in Q2 2026: 500 shares worth $1K. The stake represents ﹤0.01% of the portfolio and ranks #1152 among its holdings.

96 funds tracked by Wall St. Rank hold ABOS as of Q2 2026.

  • Avion Wealth held 500 shares of Acumen Pharmaceuticals worth $1K as of Q2 2026.
  • Acumen Pharmaceuticals was a new Avion Wealth position in Q2 2026.
  • Acumen Pharmaceuticals made up ﹤0.01% of Avion Wealth's portfolio in Q2 2026, its #1152 holding.
  • 96 funds tracked by Wall St. Rank held Acumen Pharmaceuticals as of Q2 2026.

Based on Avion Wealth's 13F filing for Q2 2026, filed 31 Jul 2026.